Photo of Kunaal Patel
Kunaal Patel
Principal
CPA
kunaal.patel@mossadams.com
(408) 558-5762
My Profile

Industry Expertise

Communications & Media Life Sciences Technology

Practice Focus

Accounting for Income Taxes (ASC 740) Accounting Methods Business Tax Credits & Incentives Financial Statement Audits IPO Solutions Outsourced Finance & Accounting SOX 404 Compliance Tax Structuring

Biography

Kunaal has practiced public accounting since 2007. He primarily assists multi-national companies in the technology, life sciences, and entertainment industries. His experience includes federal, state, and international tax compliance; ASC 740 (formerly known as FAS 109); and provision preparation and review. Kunaal also provides general tax planning for start-up, emerging growth, and publicly traded companies, and has successfully supported clients undergoing IRS and foreign audit investigations. Prior to joining Moss Adams, Kunaal spent six years working in federal tax at two Big Four firms.

Professional Affiliations

  • Member, American Institute of Certified Public Accountants
  • Member, California Society of Certified Public Accountants

Education

  • BS, corporate financial management, San Jose State University
  • MS, taxation, San Jose State University

Insights from Kunaal Patel

Article
Boost Compliance and Help Reduce Exposure by Understanding AI SALT Impacts
Navigate the complex tax implications AI software companies face when expanding operations across various jurisdictions.
Article
Webcast
2023 Year-End Tax Update for Technology and Life Sciences Companies
Navigate major tax changes and potential implications for your company at our year-end tax update webcast.
Webcast
Article
Potential Impacts of Working with Professional Employer Organizations (PEOs)
Learn about the benefits of professional employer organizations (PEOs)—as well as any potential hidden costs.
Article
Article
How to Prepare for Significant Changes with Capitalizing R&D Costs
In 2022, R&D expenses may no longer be eligible for an immediate deduction unless Congress repeals the current law.
Article
Article
How Pharmaceutical Companies Can Claim the Orphan Drug and R&D Tax Credits
Going further than the R&D tax credit, the orphan drug tax credit allows offsets up to 25% of research costs.
Article
Webcast
2021 Post-Election Tax Outlook
COVID-19 has changed the ways businesses operate and the results of the 2020 presidential election creates an opportunity for post-election tax planning.
Webcast
Article
2019 Q2 Tax Update for Technology, Communications, and Life Sciences
Changes to the tax landscape may affect your technology, communications and media, or life sciences company. Discover new tax guidance and effective dates.
Article

Baker Tilly US, LLP, Baker Tilly Advisory Group, LP and Moss Adams LLP and their affiliated entities operate under an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly Advisory Group, LP and its subsidiaries, and Baker Tilly US, LLP and its affiliated entities, trading as Baker Tilly, are members of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. Baker Tilly US, LLP and Moss Adams LLP are licensed CPA firms that provide assurance services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and consulting services to their clients and are not licensed CPA firms. ISO certification services offered through Moss Adams Certifications LLC. Investment advisory offered through either Moss Adams Wealth Advisors LLC or Baker Tilly Wealth Management, LLC.